According to Immatics's latest financial reports the company has a price-to-book ratio of 4.14.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.58 | 23.17% |
2022-12-31 | 2.91 | -90.63% |
2021-12-31 | 31.0 | 391.29% |
2020-12-31 | 6.32 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -6.34 | -253.15% | Bahamas |
NRC Health
NRC | 16.5 | 297.98% | ๐บ๐ธ USA |